• 1
    Novak N, Simon D. Atopic dermatitis – from new pathophysiologic insights to individualized therapy. Allergy 2011;66:830839.
  • 2
    Hoskins A, Roberts JL II, Milne G, Choi L, Dworski R. Natural-source d-a-tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo. Allergy 2012;67:676682.
  • 3
    Agache I, Akdis C, Jutel M, Virchow JC. Untangling asthma phenotypes and endotypes. Allergy 2012;67:835846.
  • 4
    Pezato R, Swierczynska-Krepa M, Nizankowska-Mogilnicka E, Derycke L, Bachert C, Pérez-Novo CA. Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis. Allergy 2012;67:13471356.
  • 5
    Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012;67:477490.
  • 6
    Roth N, Städtler S, Lemann M, Hösli S, Simon HU, Simon D. Distinct eosinophil cytokine expression patterns in skin diseases – the possible existence of functionally different eosinophil subpopulations. Allergy 2011;66:14771486.
  • 7
    Morshed M, Yousefi S, Stöckle C, Simon HU, Simon D. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy 2012;67:11271137.
  • 8
    Simon D, Simon HU, Yousefi S. Extracellular DNA traps in allergic, infectious, and autoimmune diseases. Allergy 2013;68:409416.
  • 9
    Dietze J, Böcking C, Heverhagen JT, Voelker MN, Renz H. Obesity lowers the threshold of allergic sensitization and augments airway eosinophilia in a mouse model of asthma. Allergy 2012;67:15191529.
  • 10
    Elishmereni M, Alenius HT, Bradding P, Mizrahi S, Shikotra A, Minai-Fleminger Y et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 2011;66:376385.
  • 11
    Elishmereni M, Bachelet I, Nissim Ben Efraim AH, Mankuta D, Levi-Schaffer F. Interacting mast cells and eosinophils acquire an enhanced activation state in vitro. Allergy 2013;68:171179.
  • 12
    Nissim Ben Efraim AH, Karra L, Ben-Zimra M, Levi-Schaffer F. The inhibitory receptor CD300a is up-regulated by hypoxia and GM-CSF in human peripheral blood eosinophils. Allergy 2013;68:397401.
  • 13
    Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Collins LP, Hunter MG et al. The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Allergy 2012;67:15721579.
  • 14
    Straumann A, Hoesli S, Bussmann Ch, Stuck M, Perkins M, Collins LP et al. Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis. Allergy 2013;68:375385.
  • 15
    Ullmann N, Bossley CJ, Fleming L, Silvestri M, Bush A, Saglani S. Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma. Allergy 2013;68:402406.
  • 16
    Khoury P, Zagallo P, Talar-Williams C, Santos CS, Dinerman E, Holland NC et al. Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome. Allergy 2012;67:11491156.
  • 17
    Simon D, Straumann A, Dahinden C, Simon H-U. Frequent sensitization to Candida albicans and profilins in adult eosinophilic esophagitis. Allergy 2013;68:945948.
  • 18
    Muniz-Junqueira MI, Barbosa-Marques SM, Junqueira LF Jr. Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children. Allergy 2013;68:911920.
  • 19
    Ueki S, Nishikawa J, Yamauchi Y, Konno Y, Tamaki M, Itoga M et al. Retinoid acids up-regulate functional eosinophil-driving receptor CCR3. Allergy 2013;68:953956.
  • 20
    Shamri R, Young KM, Weller PF. PI3K, ERK, p38 MAPK and integrins regulate CCR-mediated secretion of mouse and human eosinophil-associated RNases. Allergy 2013;68:880889.
  • 21
    Gleich GJ, Klion AD, Lee JJ, Weller PF. The consequences of not having eosinophils. Allergy 2013;68:829835.
  • 22
    Sharma SK, Almeida FA, Kierstein S, Hortobagyi L, Lin T, Larkin A et al. Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma. Allergy 2012;67:328335.
  • 23
    Lieberman JA, Morotti RA, Konstantinou GN, Yershov O, Chehade M. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy 2012;67:12991307.
  • 24
    Sandell J, Hedman J, Saarinen K, Haahtela T. Salt chamber treatment is ineffective in treating eosinophilic inflammation in asthma. Allergy 2013;68:125127.